The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; Eisai; Ipsen; MSD; Roche
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Eisai; Hengrui Pharmaceutical; Ipsen; MSD
Research Funding - Eisai; Ipsen; MSD; Sirtex Medical
Tebotelimab, a PD-1/LAG-3 bispecific antibody, in patients with advanced hepatocellular carcinoma who had failed prior targeted therapy and/or immunotherapy: An open-label, single-arm, phase 1/2 dose-escalation and expansion study.
 
Zhenggang Ren
No Relationships to Disclose
 
Yabing Guo
No Relationships to Disclose
 
Yuxian Bai
No Relationships to Disclose
 
Jieer Ying
No Relationships to Disclose
 
Zhiqiang Meng
No Relationships to Disclose
 
Zhendong Chen
No Relationships to Disclose
 
Shanzhi Gu
No Relationships to Disclose
 
Jingdong Zhang
No Relationships to Disclose
 
Jun Liang
No Relationships to Disclose
 
Xinfang Hou
No Relationships to Disclose
 
Wei Li
No Relationships to Disclose
 
Aibing Xu
No Relationships to Disclose
 
Chunyi Hao
No Relationships to Disclose
 
Jian Zhang
No Relationships to Disclose
 
Ruijun Xing
Employment - Zai Lab
Stock and Other Ownership Interests - Zai Lab
 
Xinyu Zhang
Employment - Zai Lab
Stock and Other Ownership Interests - Zai Lab
 
Dan Zhang
Employment - Zai Lab
Stock and Other Ownership Interests - Zai Lab
 
Stephen Lam Chan
No Relationships to Disclose